Compare WD 40 Company (WDFC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
WD 40 Company vs Zoetis Inc — how do they compare? WD 40 Company trades at $199.54 (market cap $2.68B), while Zoetis Inc trades at $73.83 (market cap $30.29B). The key difference: Zoetis Inc is far larger — about 11.3× WD 40 Company's market cap, and Zoetis Inc pays the higher dividend (2.89%). Which is the better fit depends on your goals.
| WDFC | ZTS | |
|---|---|---|
Market Cap | $2.68B | $30.29B |
Sector | Technology | Health |
52-Week High | $264.91 | $150.61 |
52-Week Low | $187.52 | $71.91 |
Enterprise Value | $2.74B | $37.86B |
Dividend Yield | 2.04% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WDFC trades at $201.73, down 2.81% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.33 versus $1.56 expected, and maintains a solid gross profit margin of 55.82%. Recent news highlights robust Q3 2026 results and strategic growth initiatives, including global expansion and digital enhancements.
The outlook is mixed: strong brand loyalty and earnings beats support upside, but high valuation ratios (P/E 30.37) and margin pressures from input costs pose risks. Analyst consensus is cautious with 71% hold ratings, indicating neutral sentiment amid growth potential and valuation concerns.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
